News Headlines Article

Investing in autism: Google takes a lead position
San Francisco Business Times

In Google Inc.’s game of tackling big, knotty problems with data, there are few diseases meatier than autism. The condition has two approved drugs — none of which treat a core symptom — and a wealth of misinformation that scares away some investors. But it also has a huge potential market, with an estimated one in 88 people with autism, and a growing body of data that could lend itself to genetics-based solutions, said Google Ventures partner Krishna Yeshwant.

Commands